Prednisolone for COPD exacerbations: Time for a rethink

Authors

Sanjay Ramakrishnan, Edith Cowan UniversityFollow

Document Type

Editorial

Publication Title

ERJ Open Research

Volume

9

Issue

5

Publisher

European Respiratory Society

School

School of Medical and Health Sciences

Funders

AstraZeneca

Comments

Ramakrishnan, S. (2023). Prednisolone for COPD exacerbations: time for a rethink. ERJ Open Research, 9(5). https://doi.org/10.1183/23120541.00464-2023

Abstract

Prednisolone given universally for COPD exacerbations causes harm without any benefit. Patients deserve blood eosinophil-guided prednisolone treatment for COPD exacerbations.

DOI

10.1183/23120541.00464-2023

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.